TESTBANK f#
CALCULATING DRUG DOSAGES: f# f#
A Patient-Safe Approach to Nursing and Math
f# f# f# f# f# f#
2nd Edition
f#
Castillo | Werner-McCullough
f# f#
,TEST BANK
f#
,Castillo/Werner-McCullough: f#Calculating f#Drug f#Dosages: f#A f#Patient-Safe f#Approach f#to f#Nursing f#and
f#Math,,2e f # Test f#Bank
Table f#of f#Contents:
I. Safety f#in f#Medication f#Administration
f # Chapter f#1. f#Safety f#in f#Medication
f#Administration f # Chapter f#2. f#The f#Drug
f#Label
II. Systems f#of f#Measurement
f # Chapter f#3. f#The f#Metric
f#System f # Chapter f#4. f#The
f#Household f#System
III. Methods f#of f#Calculation
Chapter f#5. f#Linear f#Ratio f#and
f#Proportion f # Chapter f#6. f#Fractional
f#Ratio f#and f#Proportion f # Chapter f#7.
f#Dimensional f#Analysis
Chapter f#8. f#Formula f#Method
IV. Administration f#of f#Medications
Chapter f#9. f#Calculating f#Oral f#Medication
f#Doses f # Chapter f#10. f#Syringes f#and
f#Needles
Chapter f#11. f#Calculating f#Parenteral f#Medication
f#Dosages f # Chapter f#12. f#Preparing f#Powdered
f#Parenteral f#Medications f # Chapter f#13.
f#Administration f#of f#Insulin
V. IV f#Therapy f#and f#Administration f#of f#Intravenous f#Medications
Chapter f#14. f#Intravenous f#Infusion f#and f#Infusion
f#Rates f # Chapter f#15. f#Calculating f#Infusion f#and
f#Completion f#Time f # Chapter f#16. f#Administering
f#IV f#Push f#Medications
VI. Verifying f#Safe f#Dose f#and f#Critical f#Care f#Calculations
Chapter f#17. f#Verifying f#Safe f#Dose
Chapter f#18. f#Titration f#of f#Intravenous f#Medications
VII. Intake f#and f#Output
Chapter f#19. f#Calculating f#Intake f#and
f#Output f # Chapter f#20. f#Calculating
f#Parenteral f#Intake
VIII. Dosages f#for f#Pediatric f#and f#Older f#Adult f#Populations
Chapter f#21. f#Considerations f#for f#the f#Pediatric
f#Patient f # Chapter f#22. f#Considerations f#for f#the
f#Older f#Adult
, Castillo/Werner-McCullough: f#Calculating f#Drug f#Dosages,
f#2e
Chapter f#1: f#Safety f#in f#Medication f#Administration
Castillo: f#Calculating f#Drug f#Dosages: f#A f#Patient-Safe f#Approach f#to f#Nursing f#and f#Math
f#2nd f#Edition
MULTIPLE f#CHOICE
1. The f#following f#medication f#order f#is f#in f#the f#patient’s f#medication f#administration
f#record f#(MAR):
methylPREDnisolone f#40 f#mg f#PO f#daily f#at f#0900.
After f#reading f#the f#order, f#the f#nurse f#correctly
f#determines: f # A “PO” f#is f#an f#inappropriate
f#abbreviation.
B the f#medication f#order f#is f#written
f#correctly. f # C 40 f#mg f#should f#be f#written
f#as f#40mg.
D tall f#man f#lettering f#indicates f#that f#the f#drug f#is f#a f#narcotic.
ANS: f#B
Feedback
The f#medication f#order f#has f#all f#the f#required f#components f#(drug f#name,
f#dose, f#route, f#and f # frequency f#of f#administration) f#for f#a f#drug f#order.
f#“PO” f#is f#an f#appropriate f#abbreviation; f # 40 f#mg f#is f#written f#correctly
f#with f#a f#space f#between f#the f#dose f#and f#the f#unit f#of f # measurement. f#Tall
f#man f#lettering f#is f#used f#to f#distinguish f#the f#drug f#from f#another f#drug
f # with f#a f#similar f#name.
2. Which f#of f#the f#following f#accurately f#describes f#the f#“Boxed f#Warning” f#found
f#on f#a f#drug f#label? f # A It f#is f#primarily f#is f#used f#to f#identify f#the f#safe
f#dose f#for f#the f#patient.
B It f#is f#commonly f#found f#on f#all f#drug f#labels.
C It f#identifies f#serious f#potential f#risks f#and f#side f#effects f#related
f#to f#drug f#use. f # D It f#protects f#the f#patient f#by f#providing
f#information f#to f#decrease f#side f#effects.
ANS: f#C
Feedback
A f#drug f#label f#with f#a f#boxed f#warning f#provides f#information f#to
f#healthcare f#professionals f # and f#patients f#regarding f#the f#serious f#risks
1
CALCULATING DRUG DOSAGES: f# f#
A Patient-Safe Approach to Nursing and Math
f# f# f# f# f# f#
2nd Edition
f#
Castillo | Werner-McCullough
f# f#
,TEST BANK
f#
,Castillo/Werner-McCullough: f#Calculating f#Drug f#Dosages: f#A f#Patient-Safe f#Approach f#to f#Nursing f#and
f#Math,,2e f # Test f#Bank
Table f#of f#Contents:
I. Safety f#in f#Medication f#Administration
f # Chapter f#1. f#Safety f#in f#Medication
f#Administration f # Chapter f#2. f#The f#Drug
f#Label
II. Systems f#of f#Measurement
f # Chapter f#3. f#The f#Metric
f#System f # Chapter f#4. f#The
f#Household f#System
III. Methods f#of f#Calculation
Chapter f#5. f#Linear f#Ratio f#and
f#Proportion f # Chapter f#6. f#Fractional
f#Ratio f#and f#Proportion f # Chapter f#7.
f#Dimensional f#Analysis
Chapter f#8. f#Formula f#Method
IV. Administration f#of f#Medications
Chapter f#9. f#Calculating f#Oral f#Medication
f#Doses f # Chapter f#10. f#Syringes f#and
f#Needles
Chapter f#11. f#Calculating f#Parenteral f#Medication
f#Dosages f # Chapter f#12. f#Preparing f#Powdered
f#Parenteral f#Medications f # Chapter f#13.
f#Administration f#of f#Insulin
V. IV f#Therapy f#and f#Administration f#of f#Intravenous f#Medications
Chapter f#14. f#Intravenous f#Infusion f#and f#Infusion
f#Rates f # Chapter f#15. f#Calculating f#Infusion f#and
f#Completion f#Time f # Chapter f#16. f#Administering
f#IV f#Push f#Medications
VI. Verifying f#Safe f#Dose f#and f#Critical f#Care f#Calculations
Chapter f#17. f#Verifying f#Safe f#Dose
Chapter f#18. f#Titration f#of f#Intravenous f#Medications
VII. Intake f#and f#Output
Chapter f#19. f#Calculating f#Intake f#and
f#Output f # Chapter f#20. f#Calculating
f#Parenteral f#Intake
VIII. Dosages f#for f#Pediatric f#and f#Older f#Adult f#Populations
Chapter f#21. f#Considerations f#for f#the f#Pediatric
f#Patient f # Chapter f#22. f#Considerations f#for f#the
f#Older f#Adult
, Castillo/Werner-McCullough: f#Calculating f#Drug f#Dosages,
f#2e
Chapter f#1: f#Safety f#in f#Medication f#Administration
Castillo: f#Calculating f#Drug f#Dosages: f#A f#Patient-Safe f#Approach f#to f#Nursing f#and f#Math
f#2nd f#Edition
MULTIPLE f#CHOICE
1. The f#following f#medication f#order f#is f#in f#the f#patient’s f#medication f#administration
f#record f#(MAR):
methylPREDnisolone f#40 f#mg f#PO f#daily f#at f#0900.
After f#reading f#the f#order, f#the f#nurse f#correctly
f#determines: f # A “PO” f#is f#an f#inappropriate
f#abbreviation.
B the f#medication f#order f#is f#written
f#correctly. f # C 40 f#mg f#should f#be f#written
f#as f#40mg.
D tall f#man f#lettering f#indicates f#that f#the f#drug f#is f#a f#narcotic.
ANS: f#B
Feedback
The f#medication f#order f#has f#all f#the f#required f#components f#(drug f#name,
f#dose, f#route, f#and f # frequency f#of f#administration) f#for f#a f#drug f#order.
f#“PO” f#is f#an f#appropriate f#abbreviation; f # 40 f#mg f#is f#written f#correctly
f#with f#a f#space f#between f#the f#dose f#and f#the f#unit f#of f # measurement. f#Tall
f#man f#lettering f#is f#used f#to f#distinguish f#the f#drug f#from f#another f#drug
f # with f#a f#similar f#name.
2. Which f#of f#the f#following f#accurately f#describes f#the f#“Boxed f#Warning” f#found
f#on f#a f#drug f#label? f # A It f#is f#primarily f#is f#used f#to f#identify f#the f#safe
f#dose f#for f#the f#patient.
B It f#is f#commonly f#found f#on f#all f#drug f#labels.
C It f#identifies f#serious f#potential f#risks f#and f#side f#effects f#related
f#to f#drug f#use. f # D It f#protects f#the f#patient f#by f#providing
f#information f#to f#decrease f#side f#effects.
ANS: f#C
Feedback
A f#drug f#label f#with f#a f#boxed f#warning f#provides f#information f#to
f#healthcare f#professionals f # and f#patients f#regarding f#the f#serious f#risks
1
